Zepp Health (ZEPP) Current Deferred Revenue (2016 - 2025)

Zepp Health has reported Current Deferred Revenue for 10 years, with the latest figure at $4.7 million in Q4 2025.

• For the quarter ending Q4 2025, Current Deferred Revenue fell 5.7% year-over-year to $4.7 million; the trailing twelve-month figure through Dec 2025 stood at $4.7 million (down 5.7% YoY), and the FY2025 full-year result was $4.7 million, down 5.7% from the prior year.
• Current Deferred Revenue for Q4 2025 stood at $4.7 million, down from $4.9 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $8.6 million in Q4 2022, with the low at $661612.6 in Q4 2021.
• Average Current Deferred Revenue over 5 years is $5.3 million, with a median of $4.9 million recorded in 2024.
• Year-over-year, Current Deferred Revenue slumped 91.53% in 2021 and soared 1199.84% in 2022.
• Tracing ZEPP's Current Deferred Revenue over 5 years: stood at $661612.6 in 2021, then soared by 1199.84% to $8.6 million in 2022, then fell by 12.82% to $7.5 million in 2023, then slumped by 34.03% to $4.9 million in 2024, then retreated by 5.7% to $4.7 million in 2025.
• The last three Current Deferred Revenue figures came in at $4.7 million (Q4 2025), $4.9 million (Q4 2024), and $7.5 million (Q4 2023), per Business Quant data.

Peer Comparison